- $93.09m
- $92.54m
- $27.64m
Brief: ImmuCell Corp Announces Pricing Of $3 Mln Public Offering Of Common Shares
Brief: Immucell Q3 loss per share $0.07
Brief: ImmuCell announces expansion of sales and marketing team
Brief: ImmuCell Q2 loss per share $0.05
Brief: Immucell enters into amendment to agreement with Plas-Pak Industries
Brief: Immucell says not treating as effective previous increase in its authorized common stock from 8 mln shares-10 mln shares
Brief: Immucell Q1 earnings per share $0.12
Brief: ImmuCell says secures $2 million in debt financing
Brief: Immucell Q4 sales fell 18 pct
Brief: Immucell files for sale of up to 659,880 shares of co's common stock
Brief: ImmuCell to raise $3.5 mln in private placement
Brief: Immucell reports preliminary Q3 2016 financial results
Brief: Immucell Corp sees FDA approval for Mast Out in 2019
Brief: Immucell posts Q2 earnings per share $0.00
Brief: Immucell Q1 earnings per share $0.11
Brief: Immucell appoints Elizabeth Williams vice president of manufacturing operations
Brief: Immucell enters into agreements covering certain credit facilities with TD Bank
Brief: ImmuCell Q4 earnings per share $0.09
Brief: Norman Pessin Reports 5.9 pct stake in ImmuCell